Silver Spring, MD, June 02, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration (FDA) today issued draft guidance to help developers bring promising gene therapies to patients more ...
In September 2025, the Food and Drug Administration (FDA) issued three draft guidance documents designed to facilitate the continued development of novel cell and gene therapies. The recommendations ...
The US Food and Drug Administration (FDA) on Monday issued draft guidance addressing key questions for drugmakers developing cell and gene therapies (CGTs). The guidance also addresses interactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results